Nassar AH, Kim SY, Aredo JV, Feng J, et al. Consolidation Osimertinib versus Durvalumab versus Observation following Concurrent Chemoradiation in Unresectable EGFR-Mutant Non-Small-Cell Lung Cancer: A Multicenter Retrospective Cohort Study. J Thorac Oncol 2024 Jan 24:S1556-0864(24)00032.
PMID: 38278303